Baltimore sues drugmaker as pharmaceutical spending rises

Frustration over the rising cost of prescription drugs may be reaching a tipping point for Maryland stakeholders. Last week, Baltimore, which runs a self-funded health plan for its employees, filed a federal lawsuit alleging a pharmaceutical company had engaged in anti-competitive practices that kept a generic version of one of its products from coming to the ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.